NCT01211860View on ClinicalTrials.gov

Pharmacokinetic Study of Diazoxide Choline in Hypertriglyeridemic Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Hypertriglyceridmia
Interventions
DRUG

Diazoxide Choline Controlled-Release Tablet

DCCR 290 mg once a day for 10 days

Trial Locations (1)

58104

Cetero, Fargo

Sponsors
All Listed Sponsors
collaborator

Cetero Research, San Antonio

NETWORK

lead

Essentialis, Inc.

INDUSTRY